LFCR
Lifecore Biomedical, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$6.40
−1.84%Margins
Gross margin
32.4%
EBITDA margin
5.7%
EBIT margin
2.4%
Net margin
-26.6%
FCF margin
—
—
Return on equity
—
Return on assets
—
Return on invested capital
—
Asset turnover
—
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2026